BNP/PUT/ALCON AG/80/0.1/21.06.24 Stock

Warrant

DE000PE85LP1

Delayed Deutsche Boerse AG 03:21:02 2024-05-29 am EDT
0.14 EUR +55.56% Intraday chart for BNP/PUT/ALCON AG/80/0.1/21.06.24
Current month-90.32%
1 month-89.66%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-05-29 0.14 +55.56%
24-05-28 0.09 +36.36%
24-05-27 0.066 -26.67%
24-05-24 0.09 +55.17%
24-05-23 0.058 -10.77%

Delayed Quote Deutsche Boerse AG

Last update May 29, 2024 at 03:21 am EDT

More quotes

Static data

Product typeWarrants
Buy / SellPUT
Underlying ALCON INC.
IssuerLogo Issuer BNP Paribas BNP Paribas
WKN PE85LP
ISINDE000PE85LP1
Date issued 2023-02-15
Strike 80 CHF
Maturity 2024-06-21 (24 Days)
Parity 10 : 1
Emission price 1.45
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 2.28
Lowest since issue 0.055
Delta-0.4x
Omega 28.17
Premium2.47x
Gearing70.94x
Moneyness 0.9894
Difference Strike -0.43 CHF
Difference Strike %-0.54%
Spread 0.01
Spread %8.33%
Intrinsic value 0.000000

Company Profile

Alcon Inc. is the global leader in the design, manufacture and marketing of ophthalmic care products. Net sales break down by category of products as follows: - ophthalmic surgical products and equipment (56.7%): consumables (51.2% of net sales), implantable products (32%) and other products (16.8%; in particular surgical equipment) for the treatment of cataracts, retinal diseases, glaucoma and refractive errors; - vision care products (43.3%): contact lenses (59.2% of sales) and eye care products (40.8%; eye drops and ophthalmic ointments, etc.) At the end of 2023, the group operated 19 production sites worldwide. Net sales are distributed geographically as follows: Switzerland (0.7%), the United States (46%), Japan (6.2%), China (5.6%) and other (41,5%).
Sector
-
More about the company

Ratings for Alcon Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings

Consensus: Alcon Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
28
Last Close Price
88.77 USD
Average target price
93.44 USD
Spread / Average Target
+5.26%
Consensus